Here, we report the regulation of STING-mediated IFNλ signaling in NSCLC, with a focus on IFNLR1 expression and the potential of chemotherapy induced IFNλ signaling as a therapeutic target in cancer treatment. This evidence concerns the gene STING1 and non-small cell lung carcinoma.